“THE POTENTIAL OF CHIMERIC ANTIGEN RECEPTOR T CELL (CART-T CELL) TARGETTING PROSTATE-SPECIFIC MEMRANE ANTIGEN (PSMA) MODIFIED BY CRISPR CAS9 AS PROSTATE CANCER THERAPY”. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, vol. 9, no. 1, July 2021, pp. 23-37, https://doi.org/10.53366/jimki.v9i1.321.